This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: University of Michigan. Active years: 2011-2018.
Company Filing History:
Years Active: 2011-2018
Title: Jessica Kollmeyer: Innovator in Autoimmune Disorder Treatments
Introduction
Jessica Kollmeyer is a prominent inventor based in Ypsilanti, MI (US). She has made significant contributions to the field of autoimmune disorders, particularly in the diagnosis and treatment of systemic lupus erythematosus. With a total of 3 patents, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Kollmeyer's latest patents focus on methods for reducing the accumulation of intracellular tingible body macrophages. The first patent describes methods for the diagnosis and treatment of systemic lupus erythematosus and drug-induced systemic lupus erythematosus. More specifically, it highlights the use of lysosomal phospholipase A2 as a therapeutic target. The second patent also emphasizes the role of lysosomal phospholipase A2 in diagnosing and treating autoimmune disorders, showcasing her commitment to advancing medical science.
Career Highlights
Jessica Kollmeyer is affiliated with the University of Michigan, where she conducts her research and develops her innovative ideas. Her work has garnered attention for its potential impact on the treatment of autoimmune diseases, making her a valuable asset in the medical research community.
Collaborations
Kollmeyer collaborates with esteemed colleagues such as Akira Abe and James A Shayman. Their combined expertise enhances the research efforts and contributes to the development of effective treatment methods.
Conclusion
Jessica Kollmeyer's contributions to the field of autoimmune disorders through her innovative patents are noteworthy. Her dedication to improving diagnosis and treatment options for systemic lupus erythematosus reflects her commitment to advancing healthcare.